10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The Lancet

• Publication date

  2009-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(09)61457-4PMID 19878986PMCID PMC3135022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes

  2009cited by this paper
• First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes

  2008cited by this paper
• The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.

  2008cited by this paper
• Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

  2007cited by this paper
• Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study.

  2006cited by this paper
• Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years After Bariatric Surgery

  2006cited by this paper
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

  2006cited by this paper
• The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)

  2006cited by this paper
• Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program.

  2005cited by this paper
• Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.

  2005cited by this paper
• Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes

  2005cited by this paper
• The burden of mortality attributable to diabetes: realistic estimates for the year 2000.

  2005cited by this paper
• Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

  2005cited by this paper
• Trying To Predict the Future for People with Diabetes: A Tough but Important Task

  2005cited by this paper
• Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

  2004cited by this paper
• Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

  2004cited by this paper
• Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.

  2003cited by this paper
• Follow-up report on the diagnosis of diabetes mellitus.

  2003cited by this paper
• Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

  2002cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Prevention of type 2 diabetes

  2001cited by this paper
• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• Applied Mixed Models in Medicine

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.

  1999cited by this paper
• Analysis of longitudinal data

  1998cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1998cited by this paper
• Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• The natural history of impaired glucose tolerance in the Pima Indians.

  1988cited by this paper
• Target Population: Members of the DPP cohort 25 years of age or older with impaired glucose tolerance. Time Horizon: Lifetime. Perspectives: Health system and societal. Interventions: Intensive lifestyle, metformin, and placebo interventions

  year unknowncited by this paper

• Doubly Robust Estimation of Desirability of Outcome Ranking (DOOR) Probability with Application to MDRO Studies

  2026cites this paper
• Weight regain after cessation of GLP-1 drugs

  2026cites this paper
• Exploring user perspectives on SMART: qualitative study of novel digital intervention targeting metabolic care in schizophrenia and related disorders

  2026cites this paper
• Circulating Asprosin Levels and Body Weight Changes in Postmenopausal Women: Findings from the Women's Health Initiative.

  2026cites this paper
• Very Low–Carbohydrate Breakfast Intervention for Adults with Type 2 Diabetes and Persistent Hyperglycemia: Protocol for a Digital, Nonrandomized Pre-Post Study

  2026cites this paper
• The Role of Lifestyle Medicine on Obesity Management in Primary Health Care: The Integration of Digitally Based Monitoring Systems

  2026cites this paper
• Lifestyle management approaches for obesity.

  2026cites this paper
• Effects of continuous glucose monitoring on physical activity and diet in diabetes: a systematic review and meta-analysis

  2026cites this paper
• Trends in the Incidence of Pediatric Type 1 Diabetes, Type 2 Diabetes, and Prediabetes Before and During the COVID-19 Pandemic.

  2026cites this paper
• An iterative mindset approach as an adjunct to the national diabetes prevention program: a randomized trial assessing retention, engagement and weight loss

  2026cites this paper
• Recruitment of individuals into a type 2 diabetes prevention program: the relative effectiveness and cost of different recruitment strategies used for the randomised controlled trial testing an Australian Lifestyle Change Program (AUS2PREVENT)

  2026cites this paper
• Weight change mediates the effect of lifestyle intervention on postpartum diabetes in women with prior gestational diabetes: a secondary analysis of a randomized clinical trial

  2026cites this paper
• Halting Progression From Prediabetes to Diabetes Through Patient Education: A Quality Improvement Project in an Underserved Community

  2026cites this paper
• Blood pressure and vascular responses during exercise in offspring of diabetes parents: The role of the muscle metaboreflex.

  2026cites this paper
• Lifestyle factors and cardiometabolic risk.

  2026cites this paper
• Pharmacotherapy for obesity management-Emphasizing the role of GLP-1 receptor agonist-based therapeutics.

  2026cites this paper
• Efficacy and safety of anti-prediabetic drugs in patients with prediabetes: a Bayesian network meta-analysis.

  2026cites this paper
• Progression to type 2 diabetes among post–myocardial infarction patients with overweight or obesity: a real-world cohort study

  2026cites this paper
• The safety and efficacy of extended use of an oral shape-shifting superabsorbent hydrogel capsule for weight loss: The ELECT extension study

  2025influential citation
• Examining the relationship between social risk factors, diabetes prevention recommendations, and behaviors among US adults with prediabetes

  2025cites this paper
• An AI-Powered Lifestyle Intervention vs Human Coaching in the Diabetes Prevention Program: A Randomized Clinical Trial.

  2025cites this paper
• Incretins for obesity: closer to a nicotine patch than a silver bullet

  2025influential citation
• Cost‐Effectiveness Analysis of an Intensive Lifestyle Intervention Versus Usual Care for Latino Youth With Prediabetes

  2025cites this paper
• The 2018 World Cancer Research Fund /American Institute for Cancer Research Score and Cancer Risk: Results from the Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline update

  2025cites this paper
• Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Fiber for improvement of behavior, eating, and risk: Protocol for a randomized controlled trial examining a behavioral intervention focused on facilitating improved dietary fiber consumption, eating behavior, and cardiometabolic risk in adults with obesity.

  2025cites this paper
• La pharmacothérapie dans la prise en charge de l’obésité chez l’adulte : mise à jour 2025 du guide de pratique clinique

  2025cites this paper
• Factors influencing type 2 diabetes in adults: a cross-sectional study

  2025cites this paper
• Effectiveness of Smartphone Application‐Based Interventions to Prevent Type 2 Diabetes Mellitus in Individuals With Prediabetes: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Nonlifestyle Treatment of Prediabetes.

  2025cites this paper
• Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations

  2025cites this paper
• Adiposity-based Chronic Diseases and the Therapeutic Role of Glucagon-like Peptide-1 Receptor Agonists

  2025cites this paper
• Academic Lifestyle Medicine and Physician Education

  2025cites this paper
• Integrated multi-omics analysis reveals the functional signature of microbes and metabolomics in pre-diabetes individuals

  2025cites this paper
• 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association

  2025cites this paper
• Long-Term Outcomes of Patient with Type 2 Diabetes Managed Under the GluCare Hybrid Care Model Using ICHOM Standards

  2025cites this paper
• Neighborhood socioeconomic disadvantage and travel time to diabetes prevention programs in Maryland.

  2025cites this paper
• Trial and Participant Characteristics of a Home-Visiting Diabetes Intervention: The Together Overcoming Diabetes Study

  2025cites this paper
• Perceptions and Experiences of Self-Management in Patients with Prediabetes: A Qualitative Study in China

  2025cites this paper
• Intermittent time‐restricted eating may increase autophagic flux in humans: an exploratory analysis

  2025cites this paper
• A brief online tool to increase behavioral weight loss treatment initiation: Protocol for a cluster randomized trial.

  2025cites this paper
• Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum

  2025influential citation
• [The role of metformin in the cardiokidney-metabolic patient].

  2025cites this paper
• Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Thirty-Year Glycemic Trajectories From Young Adulthood Through Middle Age

  2025cites this paper
• Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment

  2025cites this paper
• Development and validation of a Jordan-specific risk score for type 2 diabetes mellitus

  2025cites this paper
• Metformin’s Overall Effectiveness and Combined Action with Lifestyle Interventions in Preventing Type-2 Diabetes Mellitus in High-Risk Metformin-Naïve Patients: An Updated Systematic Review and Meta-Analysis of Published RCTs

  2025cites this paper
• Comparative effectiveness of different exercise modality on glycaemic control and lipid profile for prediabetes: systematic review and network meta-analysis

  2025cites this paper
• Race, ethnicity and ancestry in global diabetes research: grappling with complexity to advance equity and scientific integrity – a narrative review and viewpoint

  2025cites this paper
• Interventions for Weight Management in Binge-Eating Disorder: Current Findings and Issues

  2025cites this paper
• Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study.

  2025cites this paper
• Codesigning the South Asian Diet and Activity Intervention (SADAI): process and outcomes

  2025cites this paper
• Beyond Glucose—Rethinking Prediabetes for Precision Prevention

  2025cites this paper
• A randomised clinical trial to evaluate a digital therapeutic (TH-001) for improving glycaemic control in adults with prediabetes

  2025cites this paper
• Reply to “A comment on ‘Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was’”

  2025cites this paper
• Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study

  2025cites this paper
• Effectiveness of a Latino(a) Community Health Worker Led National Diabetes Prevention Program.

  2025cites this paper
• A digital health-supported community pharmacy-based lifestyle intervention program for overweight or obese adults with prediabetes, the PRediabetes Intervention, Management and Evaluation (PRIME) Program: A cluster randomized controlled trial.

  2025cites this paper
• Use of Automated Machine Learning to Detect Undiagnosed Diabetes in US Adults: Development and Validation Study

  2025cites this paper
• Relationship Between BMI and Prediabetes in Chinese Adults: A Cross-Sectional Analytical Study

  2025cites this paper
• Comparing 3 Evidence‐Based Strategies to Reduce Cardiovascular Disease Burden: An Individual‐Based Cardiometabolic Policy Simulation

  2025cites this paper
• Cost-effectiveness of advanced hepatic fibrosis screening in individuals with suspected MASLD identified by serologic noninvasive tests

  2025influential citation
• A randomized controlled trial of an acceptance and commitment therapy-informed diabetes prevention program reduces body shame and distress.

  2025cites this paper
• SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index

  2025cites this paper
• A Comprehensive 4-Layered In Silico Pharmacogenomics Analysis of the Genetic Addiction Risk Severity (GARS) Test: Strong Genetic Evidence Supporting GARS as a Novel Personalized Pre-Addiction Assessment Tool in the Opioid Crisis.

  2025cites this paper
• A cost‐effectiveness analysis alongside trial of a digital health‐supported and community pharmacy‐based prediabetes management programme (PRIME Programme) in Malaysia

  2025cites this paper
• Role of Diabetes Self-management Education for Our Health Systems and Economy.

  2025cites this paper
• Effectiveness of a low-intensity nurse-led lifestyle intervention on glycaemic control in individuals with prediabetes: The PREDIPHONE randomized controlled clinical trial.

  2025cites this paper
• Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

  2025cites this paper
• Criterion validity of the genetic addiction risk severity (GARS) as a marker of reward deficiency in polydrug addiction: a multi-center study

  2025cites this paper
• Evaluation of clinical benefits and economic value of weight loss in a Swedish population using a simulation model

  2025cites this paper
• Real‐world impact of tirzepatide on the risk of progression to type 2 diabetes and metabolic outcomes in people with obesity and pre‐diabetes

  2025cites this paper
• The role of dietary tracking on changes in dietary behaviour in a community-based diabetes prevention and management intervention

  2025cites this paper
• Prevention and Management of Prediabetes

  2025cites this paper
• Electroacupuncture modulates the gut-brain axis via the PI3K/Akt pathway to improve feeding behavior, body weight, glucolipid metabolism, and reduce insulin resistance in T2DM rats

  2025cites this paper
• Omecamtiv Mecarbil in Systolic Heart Failure: Clinical Efficacy and Future Directions of a Novel Myosin-Activating Inotropic Agent

  2025cites this paper
• Metformin Prescription Orders among Patients with Prediabetes in a National Network of Federally Qualified Health Centers

  2025cites this paper
• T2 Coach: A Qualitative Study of an Automated Health Coach for Diabetes Self-Management

  2025cites this paper
• Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial.

  2025cites this paper
• Preferences for receiving diabetes prevention support and factors influencing healthy eating and physical activity and among patients with prediabetes in Chicago, Illinois

  2025cites this paper
• Metformin use in prediabetes: A review of evidence and a focus on metabolic features among peri‐menopausal women

  2025cites this paper
• Sitagliptin Reduces Cytokine-Induced β-Cell Apoptosis in Prediabetes: A Six-Month Interventional Study.

  2025cites this paper
• Biomarkers of Insulin Resistance and Their Performance as Predictors of Treatment Response in Overweight Adults

  2025cites this paper
• Improvement of polygenic modeling of blood pressure traits using lifestyle information in the UK Biobank

  2025cites this paper
• Is there harm in behavioral lifestyle weight management for binge-eating disorder in patients with obesity: Findings from a randomized controlled trial.

  2025cites this paper
• Type 2 Diabetes Polygenic Risk Score Interactions with Lifestyle Risk Factors in Black Americans

  2025cites this paper
• Cost‐Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK

  2025cites this paper
• Impact of an adapted diabetes prevention program in a spanish primary care setting: protocol for a type II hybrid effectiveness-implementation cluster-randomized trial (ALADIM)

  2025influential citation
• Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine

  2025cites this paper
• Building diabetes prevention and remission programs across Canada: learning from England

  2025cites this paper
• Comment on Pasanisi et al. Metformin Treatment With or Without Mediterranean Diet for the Prevention of Age-Related Diseases in People With Metabolic Syndrome: The MeMeMe Randomized Trial. Diabetes Care 2025;48:265-272.

  2025cites this paper
• Evidence-based pharmacological investigation of the clinical practice and rational use of metformin in prediabetes mellitus

  2025cites this paper
• Prediabetes phenotypes: can aetiology and risk profile guide lifestyle strategies for diabetes prevention?

  2025influential citation
• Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries

  2025cites this paper
• Digital Therapeutic Based Randomized Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy: Rationale, Design, and Baseline Characteristics of the BRIGHT Trial

  2025cites this paper
• Impact of polymorphisms on gene expression and splicing in response to exercise and diet-induced weight loss in human skeletal muscle tissues

  2025cites this paper
• Prediabetes

  2025cites this paper
• Diffractive Optical Dermal Sensor for Noninvasive Arterial Pulse Wave Monitoring

  2025cites this paper